Quantitative analysis of brain edema in patients with malignant glioma treated with BCNU wafers

Satoshi Murai, Tomotsugu Ichikawa, Kazuhiko Kurozumi, Yosuke Shimazu, Tetsuo Oka, Yoshihiro Otani, Toshihiko Shimizu, Isao Date

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

BCNU wafers are a form of interstitial chemotherapy that is expected to improve the survival of patients with malignant glioma. However, their adverse events, especially brain edema, sometimes cause significant clinical symptoms. In this study, we performed a volumetric analysis of brain edema after the implantation of BCNU wafers and reported on the clinical course, and exacerbation factors of brain edema. Twelve patients who underwent surgical resection of supratentorial malignant glioma and BCNU wafer implantation, were enrolled. Radiographic quantitative analysis was conducted and compared with a historical control. The volume change in brain edema was divided into three groups and correlation with clinical symptoms was then evaluated. Compared with the control group, the brain edema in the BCNU wafer implantation group was significantly prolonged after surgery. Radiographic volumetric analysis revealed an increase of more than 25% at any time after surgery in four patients (33%) and a reduction of less than 25%, 1 month after surgery in three patients (25%). Grade 3 clinical deterioration related to brain edema occurred in two patients and Grade 2 in one patient. Univariate analysis revealed that the radiographic deterioration of brain edema had no correlation with age, sex, diagnosis, tumor grade, preoperative volume of brain edema and tumor, residual tumor volume, or number of BCNU wafers. Radiographic quantitative analysis of brain edema indicated that BCNU wafer implantation may induce the prolongation and enlargement of brain edema with or without neurological deterioration. Brain edema may be controlled by intensive perioperative treatment with diuretics and corticosteroids.

Original languageEnglish
Pages (from-to)148-153
Number of pages6
JournalJournal of Clinical Neuroscience
Volume33
DOIs
Publication statusPublished - Nov 1 2016

Fingerprint

Carmustine
Brain Edema
Glioma
Residual Volume
Residual Neoplasm
Tumor Burden
Diuretics
Brain Neoplasms
Adrenal Cortex Hormones

Keywords

  • BCNU wafer
  • Brain edema
  • Malignant glioma

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology
  • Physiology (medical)

Cite this

Quantitative analysis of brain edema in patients with malignant glioma treated with BCNU wafers. / Murai, Satoshi; Ichikawa, Tomotsugu; Kurozumi, Kazuhiko; Shimazu, Yosuke; Oka, Tetsuo; Otani, Yoshihiro; Shimizu, Toshihiko; Date, Isao.

In: Journal of Clinical Neuroscience, Vol. 33, 01.11.2016, p. 148-153.

Research output: Contribution to journalArticle

Murai, Satoshi ; Ichikawa, Tomotsugu ; Kurozumi, Kazuhiko ; Shimazu, Yosuke ; Oka, Tetsuo ; Otani, Yoshihiro ; Shimizu, Toshihiko ; Date, Isao. / Quantitative analysis of brain edema in patients with malignant glioma treated with BCNU wafers. In: Journal of Clinical Neuroscience. 2016 ; Vol. 33. pp. 148-153.
@article{65f8b0a59fe34847837847dda5ca8c07,
title = "Quantitative analysis of brain edema in patients with malignant glioma treated with BCNU wafers",
abstract = "BCNU wafers are a form of interstitial chemotherapy that is expected to improve the survival of patients with malignant glioma. However, their adverse events, especially brain edema, sometimes cause significant clinical symptoms. In this study, we performed a volumetric analysis of brain edema after the implantation of BCNU wafers and reported on the clinical course, and exacerbation factors of brain edema. Twelve patients who underwent surgical resection of supratentorial malignant glioma and BCNU wafer implantation, were enrolled. Radiographic quantitative analysis was conducted and compared with a historical control. The volume change in brain edema was divided into three groups and correlation with clinical symptoms was then evaluated. Compared with the control group, the brain edema in the BCNU wafer implantation group was significantly prolonged after surgery. Radiographic volumetric analysis revealed an increase of more than 25{\%} at any time after surgery in four patients (33{\%}) and a reduction of less than 25{\%}, 1 month after surgery in three patients (25{\%}). Grade 3 clinical deterioration related to brain edema occurred in two patients and Grade 2 in one patient. Univariate analysis revealed that the radiographic deterioration of brain edema had no correlation with age, sex, diagnosis, tumor grade, preoperative volume of brain edema and tumor, residual tumor volume, or number of BCNU wafers. Radiographic quantitative analysis of brain edema indicated that BCNU wafer implantation may induce the prolongation and enlargement of brain edema with or without neurological deterioration. Brain edema may be controlled by intensive perioperative treatment with diuretics and corticosteroids.",
keywords = "BCNU wafer, Brain edema, Malignant glioma",
author = "Satoshi Murai and Tomotsugu Ichikawa and Kazuhiko Kurozumi and Yosuke Shimazu and Tetsuo Oka and Yoshihiro Otani and Toshihiko Shimizu and Isao Date",
year = "2016",
month = "11",
day = "1",
doi = "10.1016/j.jocn.2016.03.042",
language = "English",
volume = "33",
pages = "148--153",
journal = "Journal of Clinical Neuroscience",
issn = "0967-5868",
publisher = "Churchill Livingstone",

}

TY - JOUR

T1 - Quantitative analysis of brain edema in patients with malignant glioma treated with BCNU wafers

AU - Murai, Satoshi

AU - Ichikawa, Tomotsugu

AU - Kurozumi, Kazuhiko

AU - Shimazu, Yosuke

AU - Oka, Tetsuo

AU - Otani, Yoshihiro

AU - Shimizu, Toshihiko

AU - Date, Isao

PY - 2016/11/1

Y1 - 2016/11/1

N2 - BCNU wafers are a form of interstitial chemotherapy that is expected to improve the survival of patients with malignant glioma. However, their adverse events, especially brain edema, sometimes cause significant clinical symptoms. In this study, we performed a volumetric analysis of brain edema after the implantation of BCNU wafers and reported on the clinical course, and exacerbation factors of brain edema. Twelve patients who underwent surgical resection of supratentorial malignant glioma and BCNU wafer implantation, were enrolled. Radiographic quantitative analysis was conducted and compared with a historical control. The volume change in brain edema was divided into three groups and correlation with clinical symptoms was then evaluated. Compared with the control group, the brain edema in the BCNU wafer implantation group was significantly prolonged after surgery. Radiographic volumetric analysis revealed an increase of more than 25% at any time after surgery in four patients (33%) and a reduction of less than 25%, 1 month after surgery in three patients (25%). Grade 3 clinical deterioration related to brain edema occurred in two patients and Grade 2 in one patient. Univariate analysis revealed that the radiographic deterioration of brain edema had no correlation with age, sex, diagnosis, tumor grade, preoperative volume of brain edema and tumor, residual tumor volume, or number of BCNU wafers. Radiographic quantitative analysis of brain edema indicated that BCNU wafer implantation may induce the prolongation and enlargement of brain edema with or without neurological deterioration. Brain edema may be controlled by intensive perioperative treatment with diuretics and corticosteroids.

AB - BCNU wafers are a form of interstitial chemotherapy that is expected to improve the survival of patients with malignant glioma. However, their adverse events, especially brain edema, sometimes cause significant clinical symptoms. In this study, we performed a volumetric analysis of brain edema after the implantation of BCNU wafers and reported on the clinical course, and exacerbation factors of brain edema. Twelve patients who underwent surgical resection of supratentorial malignant glioma and BCNU wafer implantation, were enrolled. Radiographic quantitative analysis was conducted and compared with a historical control. The volume change in brain edema was divided into three groups and correlation with clinical symptoms was then evaluated. Compared with the control group, the brain edema in the BCNU wafer implantation group was significantly prolonged after surgery. Radiographic volumetric analysis revealed an increase of more than 25% at any time after surgery in four patients (33%) and a reduction of less than 25%, 1 month after surgery in three patients (25%). Grade 3 clinical deterioration related to brain edema occurred in two patients and Grade 2 in one patient. Univariate analysis revealed that the radiographic deterioration of brain edema had no correlation with age, sex, diagnosis, tumor grade, preoperative volume of brain edema and tumor, residual tumor volume, or number of BCNU wafers. Radiographic quantitative analysis of brain edema indicated that BCNU wafer implantation may induce the prolongation and enlargement of brain edema with or without neurological deterioration. Brain edema may be controlled by intensive perioperative treatment with diuretics and corticosteroids.

KW - BCNU wafer

KW - Brain edema

KW - Malignant glioma

UR - http://www.scopus.com/inward/record.url?scp=84992364313&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992364313&partnerID=8YFLogxK

U2 - 10.1016/j.jocn.2016.03.042

DO - 10.1016/j.jocn.2016.03.042

M3 - Article

VL - 33

SP - 148

EP - 153

JO - Journal of Clinical Neuroscience

JF - Journal of Clinical Neuroscience

SN - 0967-5868

ER -